Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib StudyFunda Meric‐Bernstam, Shahneen Sandhu, Agostina Stradella et al.|Clinical Cancer Research|2022Cited by 226
Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas.Funda Meric‐Bernstam, Jason J. Luke, Shahneen Sandhu et al.|Journal of Clinical Oncology|2019Cited by 192
Isolation and Characterization of Circulating Tumor Cells in Patients with Metastatic Colorectal CancerSteven J. Cohen, Neal J. Meropol, R. Katherine Alpaugh et al.|Clinical Colorectal Cancer|2006Cited by 189